<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34043078</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0614</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Applied microbiology and biotechnology</Title><ISOAbbreviation>Appl Microbiol Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Development and characterization of mouse monoclonal antibodies targeting to distinct epitopes of Zika virus envelope protein for specific detection of Zika virus.</ArticleTitle><Pagination><StartPage>4663</StartPage><EndPage>4673</EndPage><MedlinePgn>4663-4673</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00253-021-11364-1</ELocationID><Abstract><AbstractText>The recent Zika virus (ZIKV) epidemic poses a serious threat to global health due to its association with microcephaly and congenital diseases in newborns and neurological complications and Guillain-Barr&#xe9; syndrome in adults. However, the majority of people infected with ZIKV do not develop symptoms. The platforms aimed to specifically diagnose ZIKV infection are needed for patient care and public health surveillance. In the study, four ZIKV envelope (E) protein-specific monoclonal antibodies (mAbs) (A1, B1, C1, and 9E-1) have been developed by using the conventional mAb technology. The binding epitopes of mAbs A1, B1, C1, and 9E-1 are located at E(238-257), E(410-431), E(258-277), and E(340-356), respectively. mAb 9E-1 performs 1.4- to 47-fold strong affinity to ZIKV E protein compared to another three mAbs. mAbs A1, C1, and 9E-1 do not have cross-reactivity against the recombinant E proteins of dengue virus serotypes 2, 3, and 4. Although these four mAbs do not have ZIKV neutralizing activity, mAbs B1 and 9E-1 have been developed as the lateral flow immunochromatographic assay for specific detection of ZIKV E protein and virions. KEY POINTS: &#x2022; The mAbs targeting to the regions of E(238-257), E(410-431), E(258-277), and E(340-356) do not have ZIKV neutralizing activity. &#x2022; The binding epitope of mAb 9E-1 is highly specific to ZIKV E protein. &#x2022; mAbs B1 and 9E-1 can bind to ZIKV virions and have been developed as the lateral flow immunochromatographic assay.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chia-Jung</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Taipei, 106, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ping-Han</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine, National Taiwan University, Taipei, 106, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hui-Wen</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine, National Taiwan University, Taipei, 106, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Shih-Chung</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5015-8178</Identifier><AffiliationInfo><Affiliation>Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Taipei, 106, Taiwan. shihchung@ntu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Biotechnology, National Taiwan University, Taipei, 106, Taiwan. shihchung@ntu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOST108-2313-B-002-011 and MOST107-2313-B-002-045</GrantID><Agency>Ministry of Science and Technology, Taiwan</Agency><Country/></Grant><Grant><GrantID>NHRI-EX109-10721SC</GrantID><Agency>National Health Research Institute, Taiwan</Agency><Country/></Grant><Grant><GrantID>108L883703 and 109L883703</GrantID><Agency>National Taiwan University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Microbiol Biotechnol</MedlineTA><NlmUniqueID>8406612</NlmUniqueID><ISSNLinking>0175-7598</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086942" MajorTopicYN="N">Viral Envelope</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="Y">Zika Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="Y">Zika Virus Infection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Envelope protein</Keyword><Keyword MajorTopicYN="N">Lateral flow immunochromatographic assay</Keyword><Keyword MajorTopicYN="N">Monoclonal antibody</Keyword><Keyword MajorTopicYN="N">Zika virus</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34043078</ArticleId><ArticleId IdType="pmc">PMC8156580</ArticleId><ArticleId IdType="doi">10.1007/s00253-021-11364-1</ArticleId><ArticleId IdType="pii">10.1007/s00253-021-11364-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney MC, Medits I, Sharma A, Simon-Loriere E, Sakuntabhai A, Cao-Lormeau VM, Haouz A, England P, Stiasny K, Mongkolsapaya J, Heinz FX, Screaton GR, Rey FA. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature. 2016;536(7614):48&#x2013;53. doi: 10.1038/nature18938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18938</ArticleId><ArticleId IdType="pubmed">27338953</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch I, de Puig H, Hiley M, Carre-Camps M, Perdomo-Celis F, Narvaez CF, Salgado DM, Senthoor D, O'Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen CW, Gelvez-Ramirez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Munoz-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, Diaz FJ, Restrepo BN, Marin K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, Gomez-Marquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L. Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Sci Transl Med. 2017;9(409):eaan1589. doi: 10.1126/scitranslmed.aan1589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aan1589</ArticleId><ArticleId IdType="pmc">PMC6612058</ArticleId><ArticleId IdType="pubmed">28954927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248&#x2013;254. doi: 10.1016/0003-2697(76)90527-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(76)90527-3</ArticleId><ArticleId IdType="pubmed">942051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng YC, Chang SC. Development and biochemical characterization of the monoclonal antibodies for specific detection of the emerging H5N8 and H5Nx avian influenza virus hemagglutinins. Appl Microbiol Biotechnol. 2021;105(1):235&#x2013;245. doi: 10.1007/s00253-020-11035-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-020-11035-7</ArticleId><ArticleId IdType="pubmed">33245391</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang YW, Li CJ, Su HY, Hsieh KT, Weng CW, Chen HW, Chang SC. Development of mouse monoclonal antibody for detecting hemagglutinin of avian influenza A(H7N9) virus and preventing virus infection. Appl Microbiol Biotechnol. 2021;105(8):3235&#x2013;3248. doi: 10.1007/s00253-021-11253-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-021-11253-7</ArticleId><ArticleId IdType="pmc">PMC7995400</ArticleId><ArticleId IdType="pubmed">33770244</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont-Rouzeyrol M, Biron A, O'Connor O, Huguon E, Descloux E. Infectious Zika viral particles in breastmilk. Lancet. 2016;387(10023):1051. doi: 10.1016/S0140-6736(16)00624-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00624-3</ArticleId><ArticleId IdType="pubmed">26944028</ArticleId></ArticleIdList></Reference><Reference><Citation>Dussupt V, Sankhala RS, Gromowski GD, Donofrio G, De La Barrera RA, Larocca RA, Zaky W, Mendez-Rivera L, Choe M, Davidson E, McCracken MK, Brien JD, Abbink P, Bai H, Bryan AL, Bias CH, Berry IM, Botero N, Cook T, Doria-Rose NA, Escuer AGI, Frimpong JA, Geretz A, Hernandez M, Hollidge BS, Jian N, Kabra K, Leggat DJ, Liu J, Pinto AK, Rutvisuttinunt W, Setliff I, Tran U, Townsley S, Doranz BJ, Rolland M, McDermott AB, Georgiev IS, Thomas R, Robb ML, Eckels KH, Barranco E, Koren M, Smith DR, Jarman RG, George SL, Stephenson KE, Barouch DH, Modjarrad K, Michael NL, Joyce MG, Krebs SJ. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor. Nat Med. 2020;26(2):228&#x2013;235. doi: 10.1038/s41591-019-0746-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0746-2</ArticleId><ArticleId IdType="pmc">PMC7018608</ArticleId><ArticleId IdType="pubmed">32015557</ArticleId></ArticleIdList></Reference><Reference><Citation>Gourinat AC, O'Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. Detection of Zika virus in urine. Emerg Infect Dis. 2015;21(1):84&#x2013;86. doi: 10.3201/eid2101.140894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2101.140894</ArticleId><ArticleId IdType="pmc">PMC4285245</ArticleId><ArticleId IdType="pubmed">25530324</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardana SA, Shaw RH. Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: panacea or pandora's box? BMC Infect Dis. 2018;18(1):641. doi: 10.1186/s12879-018-3572-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3572-0</ArticleId><ArticleId IdType="pmc">PMC6288897</ArticleId><ArticleId IdType="pubmed">30526531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YH, Lee J, Kim YE, Chong CK, Pinchemel Y, Reisdorfer F, Coelho JB, Dias RF, Bae PK, Gusmao ZPM, Ahn HJ, Nam HW. Development of a rapid diagnostic test kit to detect IgG/IgM antibody against Zika virus using monoclonal antibodies to the envelope and non-structural protein 1 of the virus. Korean J Parasitol. 2018;56(1):61&#x2013;70. doi: 10.3347/kjp.2018.56.1.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.3347/kjp.2018.56.1.61</ArticleId><ArticleId IdType="pmc">PMC5858665</ArticleId><ArticleId IdType="pubmed">29529852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindhauser MK, Allen T, Frank V, Santhana RS, Dye C. Zika: the origin and spread of a mosquito-borne virus. Bull World Health Organ. 2016;94(9):675&#x2013;686C. doi: 10.2471/BLT.16.171082.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.16.171082</ArticleId><ArticleId IdType="pmc">PMC5034643</ArticleId><ArticleId IdType="pubmed">27708473</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchette NJ, Garcia R, Rudnick A. Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg. 1969;18(3):411&#x2013;415. doi: 10.4269/ajtmh.1969.18.411.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1969.18.411</ArticleId><ArticleId IdType="pubmed">4976739</ArticleId></ArticleIdList></Reference><Reference><Citation>Musso D, Roche C, Nhan TX, Robin E, Teissier A, Cao-Lormeau VM. Detection of Zika virus in saliva. J Clin Virol. 2015;68:53&#x2013;55. doi: 10.1016/j.jcv.2015.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.04.021</ArticleId><ArticleId IdType="pubmed">26071336</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera-Lecoin M, Meertens L, Carnec X, Amara A. Flavivirus entry receptors: an update. Viruses. 2013;6(1):69&#x2013;88. doi: 10.3390/v6010069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6010069</ArticleId><ArticleId IdType="pmc">PMC3917432</ArticleId><ArticleId IdType="pubmed">24381034</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan MJ, Wilson PC, Ahmed R, Suthar MS, Wrammert J. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A. 2016;113(28):7852&#x2013;7857. doi: 10.1073/pnas.1607931113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607931113</ArticleId><ArticleId IdType="pmc">PMC4948328</ArticleId><ArticleId IdType="pubmed">27354515</ArticleId></ArticleIdList></Reference><Reference><Citation>Roby JA, Setoh YX, Hall RA, Khromykh AA. Post-translational regulation and modifications of flavivirus structural proteins. J Gen Virol. 2015;96(Pt 7):1551&#x2013;1569. doi: 10.1099/vir.0.000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000097</ArticleId><ArticleId IdType="pubmed">25711963</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin YC, Tang SJ, Chen JH, Liao PH, Chang SC. The molecular determinants of NEDD8 specific recognition by human SENP8. PLoS One. 2011;6(11):e27742. doi: 10.1371/journal.pone.0027742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027742</ArticleId><ArticleId IdType="pmc">PMC3215745</ArticleId><ArticleId IdType="pubmed">22110750</ArticleId></ArticleIdList></Reference><Reference><Citation>Slon Campos JL, Mongkolsapaya J, Screaton GR. The immune response against flaviviruses. Nat Immunol. 2018;19(11):1189&#x2013;1198. doi: 10.1038/s41590-018-0210-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0210-3</ArticleId><ArticleId IdType="pubmed">30333606</ArticleId></ArticleIdList></Reference><Reference><Citation>Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 2016;353(6301):823&#x2013;826. doi: 10.1126/science.aaf8505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf8505</ArticleId><ArticleId IdType="pubmed">27417494</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanstrom JA, Plante JA, Plante KS, Young EF, McGowan E, Gallichotte EN, Widman DG, Heise MT, de Silva AM, Baric RS. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. mBio. 2016;7(4):e01123-16. doi: 10.1128/mBio.01123-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01123-16</ArticleId><ArticleId IdType="pmc">PMC4958264</ArticleId><ArticleId IdType="pubmed">27435464</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang R, Wang L, Ben H, Yu L, Gao F, Shi X, Yin C, Zhang F, Xiang Y, Zhang L. Structural basis for neutralization and protection by a Zika virus-specific human antibody. Cell Rep. 2019;26(12):3360&#x2013;3368. doi: 10.1016/j.celrep.2019.02.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.02.062</ArticleId><ArticleId IdType="pubmed">30893607</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Dent M, Lai H, Sun H, Chen Q. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Vaccine. 2017;35(33):4287&#x2013;4294. doi: 10.1016/j.vaccine.2017.04.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.04.052</ArticleId><ArticleId IdType="pmc">PMC5546088</ArticleId><ArticleId IdType="pubmed">28669618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Kostyuchenko VA, Ng TS, Lim XN, Ooi JSG, Lambert S, Tan TY, Widman DG, Shi J, Baric RS, Lok SM. Neutralization mechanism of a highly potent antibody against Zika virus. Nat Commun. 2016;7:13679. doi: 10.1038/ncomms13679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13679</ArticleId><ArticleId IdType="pmc">PMC5123051</ArticleId><ArticleId IdType="pubmed">27882950</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Du X, Chen C, Chen Z, Zhang L, Han Q, Xia X, Song Y, Zhang J. Development and characterization of double-antibody sandwich ELISA for detection of Zika virus infection. Viruses. 2018;10(11):634. doi: 10.3390/v10110634.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10110634</ArticleId><ArticleId IdType="pmc">PMC6266115</ArticleId><ArticleId IdType="pubmed">30445676</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Fernandez E, Dowd KA, Speer SD, Platt DJ, Gorman MJ, Govero J, Nelson CA, Pierson TC, Diamond MS, Fremont DH. Structural basis of Zika virus-specific antibody protection. Cell. 2016;166(4):1016&#x2013;1027. doi: 10.1016/j.cell.2016.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.07.020</ArticleId><ArticleId IdType="pmc">PMC4983199</ArticleId><ArticleId IdType="pubmed">27475895</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>